@florencevb.bsky.social
MD, MSc | PhD Candidate at the Netherlands Cancer Institute
precision oncology | (immuno)therapy resistance | obesity
precision oncology | (immuno)therapy resistance | obesity
Reposted
Taking over the hospital for prideweek with gendercupcakes
@nkinl.bsky.social @florencevb.bsky.social #diversity
@nkinl.bsky.social @florencevb.bsky.social #diversity
July 29, 2025 at 12:26 PM
Taking over the hospital for prideweek with gendercupcakes
@nkinl.bsky.social @florencevb.bsky.social #diversity
@nkinl.bsky.social @florencevb.bsky.social #diversity
Drop by poster P-556 today between 18:30-20:00 and check out some of the first work of my PhD: “Trametinib for NRAS-mutated tumors: results from the Drug Rediscovery Protocol (DRUP)”. See you there! #EACR2025 👯♀️👩🏼🔬
June 17, 2025 at 2:41 PM
Drop by poster P-556 today between 18:30-20:00 and check out some of the first work of my PhD: “Trametinib for NRAS-mutated tumors: results from the Drug Rediscovery Protocol (DRUP)”. See you there! #EACR2025 👯♀️👩🏼🔬
Reposted
FDA new drug approvals in Q1 2025 tinyurl.com/5n8ak54h
Only 7 new drugs were approved by the FDA in Q1, but 2 are potential blockbusters - the sodium channel inhibitor suzetigrine for pain and TROP2-targeted ADC datopotamab deruxtecan for breast cancer
Only 7 new drugs were approved by the FDA in Q1, but 2 are potential blockbusters - the sodium channel inhibitor suzetigrine for pain and TROP2-targeted ADC datopotamab deruxtecan for breast cancer
April 14, 2025 at 1:56 PM
FDA new drug approvals in Q1 2025 tinyurl.com/5n8ak54h
Only 7 new drugs were approved by the FDA in Q1, but 2 are potential blockbusters - the sodium channel inhibitor suzetigrine for pain and TROP2-targeted ADC datopotamab deruxtecan for breast cancer
Only 7 new drugs were approved by the FDA in Q1, but 2 are potential blockbusters - the sodium channel inhibitor suzetigrine for pain and TROP2-targeted ADC datopotamab deruxtecan for breast cancer
Very inspirational two days at the Clinical Cancer Genomics conference in Amsterdam! Lots of interesting speakers on the current state of genomics and proteomics for biomarker identification and treatment decisions in daily oncological clinical practice. #CCG2025 #HartwigMedicalFoundation
March 21, 2025 at 12:57 PM
Very inspirational two days at the Clinical Cancer Genomics conference in Amsterdam! Lots of interesting speakers on the current state of genomics and proteomics for biomarker identification and treatment decisions in daily oncological clinical practice. #CCG2025 #HartwigMedicalFoundation
Reposted
Living alone for several years and/or experiencing serial relationship break-ups are strongly linked to raised levels of inflammatory markers in the blood–but only in men
jech.bmj.com/content/76/5...
jech.bmj.com/content/76/5...
January 18, 2025 at 5:23 PM
Living alone for several years and/or experiencing serial relationship break-ups are strongly linked to raised levels of inflammatory markers in the blood–but only in men
jech.bmj.com/content/76/5...
jech.bmj.com/content/76/5...
Reposted
Top 4 things to know about doing science:
1. You need to have someone you can talk to
2. One-on-one discussions are the best
3. Think about discussions as improvisations and use the ‘yes, and’ rule
4. Create a safe space so both of you feel open to saying seemingly silly things
1. You need to have someone you can talk to
2. One-on-one discussions are the best
3. Think about discussions as improvisations and use the ‘yes, and’ rule
4. Create a safe space so both of you feel open to saying seemingly silly things
January 13, 2025 at 1:52 AM
Top 4 things to know about doing science:
1. You need to have someone you can talk to
2. One-on-one discussions are the best
3. Think about discussions as improvisations and use the ‘yes, and’ rule
4. Create a safe space so both of you feel open to saying seemingly silly things
1. You need to have someone you can talk to
2. One-on-one discussions are the best
3. Think about discussions as improvisations and use the ‘yes, and’ rule
4. Create a safe space so both of you feel open to saying seemingly silly things